Valsartan and Hydrochlorothiazide
- Product NDC
- 57297-105
- 11-digit product format
- 572970105
- Labeler code
- 57297
- Product ID
- 57297-105_a3f79bb0-6766-40fd-9817-4b84ec840930
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Valsartan and Hydrochlorothiazide
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- LUPIN LIMITED
- Application
- ANDA078946
- Marketing category
- ANDA
- Marketing start
- 2013-03-21
- Marketing end
- 0000-00-00
- Substance
- HYDROCHLOROTHIAZIDE; VALSARTAN
- Active strength
- 25 mg/1; mg/1
- Pharmacologic classes
- Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS],Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC]
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 57297-105-02 | 2024-12-19 | C162847 | 48780-1 | 9d75b9d0-d7b6-f424-e053-dadaa90a57ce | ca3140a4-55a3-4cef-ae64-04f634d7e7b7 |
| 57297-105-03 | 2024-12-19 | C162847 | 48780-1 | 9d75b9d0-d7b6-f424-e053-dadaa90a57ce | ca3140a4-55a3-4cef-ae64-04f634d7e7b7 |
| 57297-105-09 | 2024-12-19 | C162847 | 48780-1 | 9d75b9d0-d7b6-f424-e053-dadaa90a57ce | ca3140a4-55a3-4cef-ae64-04f634d7e7b7 |
| 57297-105-11 | 2024-12-19 | C162847 | 48780-1 | 9d75b9d0-d7b6-f424-e053-dadaa90a57ce | ca3140a4-55a3-4cef-ae64-04f634d7e7b7 |
| 57297-105-02 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-d7b6-f424-e053-dadaa90a57ce | ca3140a4-55a3-4cef-ae64-04f634d7e7b7 |
| 57297-105-03 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-d7b6-f424-e053-dadaa90a57ce | ca3140a4-55a3-4cef-ae64-04f634d7e7b7 |
| 57297-105-09 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-d7b6-f424-e053-dadaa90a57ce | ca3140a4-55a3-4cef-ae64-04f634d7e7b7 |
| 57297-105-11 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-d7b6-f424-e053-dadaa90a57ce | ca3140a4-55a3-4cef-ae64-04f634d7e7b7 |